Special Issue "Signaling Systems in Pseudomonas aeruginosa Biofilm"
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (30 October 2017) | Viewed by 21199
Interests: signaling systems; quorum sensing; biofilm; Pseudomonas aeruginosa; antimicrobial research; anti-virulence; quorum sensing inhibition
Up until the 1970s, bacteria were understood to live as single organisms (planktonic mode of life), floating or actively swimming in their respective environments. This perception was challenged by the discovery that bacteria can live as organized aggregated communities, termed biofilms, and today the biofilm mode of growth is considered the favored life form of bacteria. Biofilm formation in the environment is believed to be an ancient strategy by which bacteria increase their survival potential in hostile environments. Extensive investigations support this to also be valid for biofilm related infections where the bacteria show highly elevated tolerance towards antibiotics and the immune system, compared with planktonic cells. Several signaling systems have been shown to be involved in different aspects of biofilm formation and maintenance, not least Quorum Sensing (QS) and cyclic-di-GMP. The importance of such signaling systems is supported by the growing identification of how factors regulated by these systems favor survival potentials of pathogens like Pseudomonas aeruginosa. Our knowledge of signaling systems is constantly evolving and new components taking part in the regulation are discovered.
Treatment of biofilm infections is significantly more difficult and complex compared to the relatively simple task of treating acute infections. Inhibition of signaling systems like QS and cyclic-di-GMP has gained considerable attention as potential approaches in the attempt to develop new strategies against biofilms. This Special Issue in Pathogens on “Signaling Systems in Pseudomonas aeruginosa Biofilm” centers on the newest studies and current knowledge about the influence of signaling systems on P. aeruginosa biofilm, both in vitro and in vivo, as well as on the potential of modulating these regulatory systems to lower biofilm survival. We invite you to submit a research or review manuscripts covering these important molecular aspects of P. aeruginosa biofilm and look forward to contributions that can increase our understanding and knowledge of this important scientific field.
Prof. Dr. Tim Holm Jakobsen
Prof. Jens Bo Andersen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- signaling systems
- quorum sensing
- Gac/rsm cascade
- Pseudomonas aeruginosa
- quorum sensing inhibitors
- cyclic-di-GMP inhibitors